144 related articles for article (PubMed ID: 35281756)
1. Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study.
Meems LMG; Artola Arita V; Velt M; Dudink EAMP; Crijns HJGM; Van Gelder IC; Rienstra M
Int J Cardiol Heart Vasc; 2022 Apr; 39():100987. PubMed ID: 35281756
[TBL] [Abstract][Full Text] [Related]
2. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.
Santema BT; Chan MMY; Tromp J; Dokter M; van der Wal HH; Emmens JE; Takens J; Samani NJ; Ng LL; Lang CC; van der Meer P; Ter Maaten JM; Damman K; Dickstein K; Cleland JG; Zannad F; Anker SD; Metra M; van der Harst P; de Boer RA; van Veldhuisen DJ; Rienstra M; Lam CSP; Voors AA
Clin Res Cardiol; 2020 Mar; 109(3):331-338. PubMed ID: 31263996
[TBL] [Abstract][Full Text] [Related]
3. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
[TBL] [Abstract][Full Text] [Related]
4. The intracardiac concentrations of the N-terminal-pro B-type natriuretic peptide (NT-proBNP) and the determinants of its secretion in patients with atrial fibrillation.
Streb W; Mitręga K; Szymała M; Woźniak A; Podolecki T; Kalarus Z
Kardiol Pol; 2018; 76(2):433-439. PubMed ID: 29131295
[TBL] [Abstract][Full Text] [Related]
5. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
Berg DD; Ruff CT; Jarolim P; Giugliano RP; Nordio F; Lanz HJ; Mercuri MF; Antman EM; Braunwald E; Morrow DA
Circulation; 2019 Feb; 139(6):760-771. PubMed ID: 30586727
[TBL] [Abstract][Full Text] [Related]
6. Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.
Kerr B; Brandon L
Int J Cardiol Heart Vasc; 2022 Dec; 43():101132. PubMed ID: 36246770
[TBL] [Abstract][Full Text] [Related]
7. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
[TBL] [Abstract][Full Text] [Related]
8. Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
Oyama K; Giugliano RP; Berg DD; Ruff CT; Jarolim P; Tang M; Murphy SA; Lanz HJ; Grosso MA; Antman EM; Braunwald E; Morrow DA
Eur Heart J; 2021 May; 42(17):1698-1706. PubMed ID: 33760027
[TBL] [Abstract][Full Text] [Related]
9. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
[TBL] [Abstract][Full Text] [Related]
11. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
Hamatani Y; Iguchi M; Ueno K; Aono Y; Esato M; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Morita S; Akao M
Heart; 2021 May; 107(9):705-712. PubMed ID: 33219109
[TBL] [Abstract][Full Text] [Related]
13. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.
Ma XX; Zhang YL; Hu B; Jiang WJ; Wang M; Zheng DY; Zhu MR; Xue XP
J Interv Card Electrophysiol; 2017 Apr; 48(3):343-350. PubMed ID: 27943042
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
15. Estimation of atrial fibrillation recency of onset and safety of cardioversion using NTproBNP levels in patients with unknown time of onset.
Deftereos S; Giannopoulos G; Kossyvakis C; Raisakis K; Kaoukis A; Aggeli C; Toli K; Theodorakis A; Panagopoulou V; Driva M; Mantas I; Pyrgakis V; Rentoukas I; Stefanadis C
Heart; 2011 Jun; 97(11):914-7. PubMed ID: 21303795
[TBL] [Abstract][Full Text] [Related]
16. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
[TBL] [Abstract][Full Text] [Related]
17. Biological significance of miR-126 expression in atrial fibrillation and heart failure.
Wei XJ; Han M; Yang FY; Wei GC; Liang ZG; Yao H; Ji CW; Xie RS; Gong CL; Tian Y
Braz J Med Biol Res; 2015 Nov; 48(11):983-9. PubMed ID: 26313139
[TBL] [Abstract][Full Text] [Related]
18. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
Xiao J; Persson AP; Engström G; Johnson LSB
BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
[TBL] [Abstract][Full Text] [Related]
19. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in atrial fibrillation and heart failure with non-reduced ejection fraction: Diagnostic application and new cut-off points.
Merino-Merino A; Saez-Maleta R; Salgado-Aranda R; AlKassam-Martinez D; Pascual-Tejerina V; Martin-Gonzalez J; Garcia-Fernandez J; Perez-Rivera JA
Heart Lung; 2020; 49(4):388-392. PubMed ID: 32145960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
